Actair

Actair is a sublingual immunotherapy treatment designed to help manage allergies caused by house dust mites. This product contains extracts of Dermatophagoides Pteronyssinus and Dermatophagoides Farinae, commonly found in household dust. It is intended for sublingual use and is manufactured by Stallergenes.

Actair is primarily used for the treatment of allergic rhinitis and asthma triggered by house dust mites. This sublingual immunotherapy aims to reduce sensitivity to allergens, potentially alleviating symptoms such as sneezing, nasal congestion, and itchy eyes. It is often considered for individuals who experience persistent allergic reactions to dust mites.

Common effects of Actair may include temporary local reactions at the site of administration, such as itching or swelling under the tongue. Some users might experience mild gastrointestinal discomfort. These effects are generally short-lived and should be monitored. Always consult a healthcare provider for any persistent or severe reactions.

Actair should be used under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration instructions carefully. Individuals with a history of severe allergic reactions or asthma should exercise caution. Keep the product out of reach of children and store it as directed to maintain its efficacy.

Actair may interact with other medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking. Avoid consuming alcohol while using Actair, as it may exacerbate potential side effects. Always consult a healthcare professional before starting any new treatment.